信邦制药：8月28日召开董事会会议

Company Overview - Xinfang Pharmaceutical (SZ 002390) announced its 8th meeting of the 9th Board of Directors held on August 28, 2025, in Guiyang, Guizhou Province, focusing on the revision of the "Audit Committee Work Rules" [1] Financial Performance - For the first half of 2025, Xinfang Pharmaceutical's revenue composition was as follows: pharmaceutical distribution accounted for 75.12%, medical services 27.8%, pharmaceutical manufacturing 17.27%, other industries 0.03%, and consolidation adjustments at -20.23% [1]